The Conversation (0)
Nuvilex Inc. (OTCQB:NVLX), an international biotechnology company, said its Cell-in-a-Box ™ technology could help stem cell companies overcome roadblocks that prevent them from succeeding.
Nuvilex Inc. (OTCQB:NVLX), an international biotechnology company, said its Cell-in-a-Box ™ technology could help stem cell companies overcome roadblocks that prevent them from succeeding.
As quoted in the press release:
Meanwhile, Nuvilex, a biotech headquartered in Silver Spring, Maryland, is currently in negotiations with biotechnology and pharmaceutical entities that wish to examine the employment of Nuvilex’s living cell encapsulation technology, or Cell-in-a-Box™, in the development of treatments for various diseases that would utilize stem cells.
Click here to read the full Nuvilex Inc. (OTCQB:NVLX) press release.
